Zobrazeno 1 - 10
of 2 263
pro vyhledávání: '"anti‐tumor immunity"'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 13615-13651 (2024)
Renwei Li,1,* Jing Huang,2,* Yuhao Wei,1 Yusha Wang,1,3 Can Lu,4,5 Jifeng Liu,6,7 Xuelei Ma1 1Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P
Externí odkaz:
https://doaj.org/article/c2e355205008416aab1ce150555db187
Autor:
Liam F. Spurr, Sean P. Pitroda
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Recent studies have linked elevated tumor aneuploidy to anti-tumor immune suppression and adverse survival following immunotherapy. Herein, we provide supportive evidence for tumor aneuploidy as a biomarker of response to immunotherapy in pa
Externí odkaz:
https://doaj.org/article/27afba756f854d3d8ae09d61094408de
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The use of pesticides has enabled the development of contemporary industrial agriculture and significantly increased crop yields. However, they are also considered a source of environmental pollution and a potential hazard to human health. Despite na
Externí odkaz:
https://doaj.org/article/db1a54e87a8c4081b4801014010f24c2
Autor:
Sara Maria Majernikova
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Treating non-small-cell lung cancer (NSCLC) has gained increased importance in recent years due to the high mortality rate and dismal five-year survival rate. Immune checkpoint inhibitors (ICI) are a promising approach with exceptional outcomes in NS
Externí odkaz:
https://doaj.org/article/98ae7c59933b4acebe4b1abaecfdce62
Autor:
Run Xing Luo, Huai Liang Li, Yu Xiang Jia, Meng Gao, Zhao Yang Gao, Yi Ji, Shan Deng, Jie Ge Huo, Jian Zhang, Dong Jian Zhang
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39071- (2024)
The traditional Chinese medicine (TCM) formulation Shengqiyichang Decoction (SQYCD) has been reported to stimulate host immunity, and it has been administered for the treatment of colorectal cancer (CRC). Here, we applied network and bioinformatics a
Externí odkaz:
https://doaj.org/article/f6434f7c2a304f519ca76f128b5b32fa
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background In triple-negative breast cancer (TNBC) therapy, insufficient tumor infiltration by lymphocytes significantly hinders the efficacy of immune checkpoint inhibitors. We have previously demonstrated that Hainanenin-1 (HN-1), a host d
Externí odkaz:
https://doaj.org/article/4e8922e57b7c443bbe67f7c718280b7a
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract Chemotherapy and immunotherapy have shown no significant outcome for unresectable pancreatic ductal adenocarcinoma (PDAC). Multi-drug combination therapy has become a consensus in clinical trials to explore how to arouse anti-tumor immunity
Externí odkaz:
https://doaj.org/article/636570c8b9454344bfa1c84aa7444ff6
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-20 (2024)
Abstract Background Telomerase, by safeguarding damaged telomeres and bolstering DNA damage repair, has the capacity to heighten the radioresistance of tumour cells. Thus, in turn, can compromise the efficacy of radiotherapy (RT) and radioimmunothera
Externí odkaz:
https://doaj.org/article/56775fe79e2c4b5487b985d449e20b9f
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-17 (2024)
Abstract Interleukin-12 (IL-12) can be used as an immunomodulator in cancer immunotherapy. And it has demonstrated enormous potential in inhibiting tumor growth and improving the tumor microenvironment (TME) by several preclinical models. However, so
Externí odkaz:
https://doaj.org/article/e085a92bf1b14525b5e043b99a1587b8